1. Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Issue 7 (14th November 2016) Authors: Bollard, Julien; Miguela, Verónica; Ruiz de Galarreta, Marina; Venkatesh, Anu; Bian, C Billie; Roberto, Mark P; Tovar, Victoria; Sia, Daniela; Molina-Sánchez, Pedro; Nguyen, Christie B; Nakagawa, Shigeki; Llovet, Josep M; Hoshida, Yujin; Lujambio, Amaia Journal: Gut Issue: Volume 66:Issue 7(2017) Page Start: 1286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Issue 3 (11th December 2015) Authors: Tovar, Victoria; Cornella, Helena; Moeini, Agrin; Vidal, Samuel; Hoshida, Yujin; Sia, Daniela; Peix, Judit; Cabellos, Laia; Alsinet, Clara; Torrecilla, Sara; Martinez-Quetglas, Iris; Lozano, Juan José; Desbois-Mouthon, Christèle; Solé, Manel; Domingo-Domenech, Josep; Villanueva, Augusto; Llovet, ... Journal: Gut Issue: Volume 66:Issue 3(2017) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗